Bio-Techne

Yahoo Finance • 9 days ago

3 Small-Cap Stocks That Fall Short

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to... Full story

Yahoo Finance • 11 days ago

1 S&P 500 Stock to Own for Decades and 2 We Question

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, decl... Full story

Yahoo Finance • 22 days ago

Nasdaq, S&P 500, Dow futures slip as hopes of U.S.-Iran resolution fade

[Lower Manhattan skyscrapers, New York City] Stock index futures were lower before the opening bell as hopes of a resolution to the U.S.-Iran conflict waned following warnings from President Donald Trump of a major escalation. Nasdaq 100... Full story

Yahoo Finance • last month

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 2 months ago

What Makes Bio-Techne Corporation (TECH) a Good Investment?

Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for “Madison Mid Cap Fund”. A copy of the letter can be downloaded here. The Russell Midcap Index ended an incredibly successful three-year run wi... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Bayer, Hims & Hers and Select Medical in focus

Wall Street's major averages ended lower on Friday after nonfarm payrolls unexpectedly contracted in February and oil prices continued to rise. The benchmark S&P 500 closed -1.3%, while the Nasdaq Composite finished -1.6%, and the Dow end... Full story

Yahoo Finance • 2 months ago

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

Bio-Techne trades at $56.99 and has moved in lockstep with the market. Its shares have returned 7.7% over the last six months while the S&P 500 has gained 5.7%. Is there a buying opportunity in Bio-Techne, or does it present a risk to you... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

Wall Street’s major market averages concluded higher on Friday as investors reacted to the latest PCE inflation report, which came in hotter than expected. The tech-focused Nasdaq Composite ended +0.9%. At the same time, the benchmark S&P... Full story

Yahoo Finance • 2 months ago

Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU

(RTTNews) - Bio-Techne Corp. (TECH) said its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European Union. The CE-IVD certification allows hospitals, clinical laboratories... Full story

Yahoo Finance • 2 months ago

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time Provides confidenc... Full story

Yahoo Finance • 3 months ago

Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ...

This article first appeared on GuruFocus. Adjusted EPS: $0.46, up 10% year-over-year. GAAP EPS: $0.24, up from $0.22 in the prior year period. Total Revenue: $295.9 million, flat year-over-year on both an organic and reported basis. Adjus... Full story

Yahoo Finance • 3 months ago

Bio-Techne Q2 Earnings Call Highlights

Bio-Techne logo Key Points Bio‑Techne reported organic revenue flat in Q2 as strength from large pharma was offset by softness in emerging biotech and U.S. academia and a near‑term pause in GMP reagent buys from two large cell‑therapy cu... Full story

Yahoo Finance • 3 months ago

Bio-Techne (TECH) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, February 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Kim Kelderman Chief Financial Officer — James T. Hippel Full Conference Call Transcript Kim Kel... Full story

Yahoo Finance • 3 months ago

Bio-Techne Q2 26 Earnings Conference Call At 9:00 AM ET

(RTTNews) - Bio-Techne Corp (TECH) will host a conference call at 9:00 AM ET on February 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.bio-techne.com/ir-calendar To listen to the call... Full story

Yahoo Finance • 4 months ago

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13,... Full story

Yahoo Finance • 5 months ago

Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Nasdaq (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) ending the week in the red as the AI trade came under... Full story

Yahoo Finance • 5 months ago

Here’s Why BioTechne (TECH) Traded Lower in Q3

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the market’s concentration persists, with a few... Full story

Yahoo Finance • 5 months ago

Bio-Techne Announces Expanded Launch Of Next-Generation Leo System

(RTTNews) - Bio-Techne Corp. (TECH), Tuesday announced the expanded launch and first shipment of its next-generation Leo System, expecting to deliver unmatched precision and efficiency in protein analysis. Powered by Simple Western Techno... Full story

Yahoo Finance • 5 months ago

Bio-Techne Corporation (TECH): A Bull Case Theory

We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was trading at $64.63 as of November 26th. TECH’s trai... Full story

Yahoo Finance • 5 months ago

Bio-Techne (TECH): Evaluating Valuation After ACA Subsidy Extension Boosts Market Sentiment

Bio-Techne (TECH) stock saw a quick boost as investors responded to reports that the Trump administration is considering a two-year extension of Affordable Care Act subsidies. This development is easing some regulatory uncertainty for the... Full story